Cardiovascular Effects of Beta-Blockers with and without Intrinsic Sympathomimetic Activity

Publisher： Karger

E-ISSN： 1423-0143|25|1|34-41

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.25, Iss.1, 2002-02, pp. : 34-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 136-145

Karger

Access to resources Recommend Favorite

Cardiovascular Mortality in Haemodialysis Patients Treated with Epoetin Beta – A Retrospective Study

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 455-462

Karger

Access to resources Recommend Favorite

Effects of Anemia and Uremia and a Combination of Both on Cardiovascular Structures

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 4, 2010-07 ,pp. : 274-281

Karger

Access to resources Recommend Favorite

Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 3, 2010-06 ,pp. : 213-220

Karger

Access to resources Recommend Favorite

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 6, 2014-12 ,pp. : 573-580

Karger

Access to resources Recommend Favorite